한글목차

조산 및 PROM 검사 시장은 2025년 19억 2,000만 달러, 2032년에는 29억 4,000만 달러에 이를 것으로 예측되며, 2025-2032년 CAGR 6.3%를 나타낼 전망입니다.

미숙아 출산은 조산이라고도 불리며, 전 세계적인 건강 문제입니다. 조산이란 임신 37주 미만의 출산을 말합니다. 세계보건기구(WHO)에 따르면 매년 약 1,500만 명의 아기가 조산으로 태어나고 있으며, 이는 전 세계 출생아 중 약 10명 중 1명을 차지합니다. 조산은 다양한 건강 합병증을 유발할 수 있으며, 신생아 사망률과 이환율의 주요 원인 중 하나입니다.

PROM 검사는 분만 전 막파열을 의미하며, 조산의 위험을 평가하기 위해 사용되는 중요한 진단 도구입니다. 진통이 시작되기 전에 양막파열을 조기에 발견하는 데 도움이 됩니다. 양수의 존재를 감지함으로써 PROM 검사는 의료 전문가가 조산 위험이 있는 임산부의 관리 및 치료에 대한 정보에 입각한 결정을 내리는 데 도움이 됩니다.

시장 역학:

조산 및 PROM 검사 시장은 주로 전 세계 조산 발생률 증가에 의해 주도되고 있습니다. 산모의 나이, 다태 임신, 불충분한 임산부 관리, 감염, 사회경제적 요인 등이 조산 증가에 기여하고 있으며, PROM 검사는 조산의 위험을 식별하고 의료 전문가가 적시에 개입하여 신생아의 결과를 개선하는 데 중요한 역할을 합니다.

그러나 시장 성장을 저해하는 요인도 있습니다. PROM 검사 키트의 높은 가격, 개발도상국에서는 의료 시설에 대한 접근성이 제한적이라는 점, 임산부 및 의료 종사자들 사이에서 조산 및 PROM 검사에 대한 인식이 낮다는 점 등이 그 예입니다.

한편, PROM 검사법의 기술적 진보, 현장 검사에 대한 관심 증가, 개인 맞춤형 의료에 대한 수요 증가 등을 배경으로 시장에는 큰 비즈니스 기회가 존재합니다. 시장 개발 기업들은 정확성, 사용 편의성, 비용 효율성을 개선한 혁신적인 PROM 검사 키트를 개발하기 위해 연구개발 활동에 투자하고 있습니다.

전반적으로 조산 및 PROM 검사 시장은 조산에 대한 인식 증가, PROM 검사법의 발전, 신생아 예후를 개선하기 위한 조기 발견 및 조기 개입의 필요성에 힘입어 크게 성장하고 있습니다. 시장 참여자들은 제품 포트폴리오를 확장하고, 주요 이해관계자들과 협력하며, 미개발된 시장 잠재력을 발굴하기 위한 전략을 수립하고 있습니다.

본 조사의 주요 특징

• 세계의 조산 및 PROM 검사 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 2025-2032년까지의 예측 기간 시장 규모와 연평균 성장률(CAGR)을 조사 분석하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 고찰을 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개 변수를 기반으로 세계 조산 및 PROM 검사 시장의 주요 기업 프로파일을 제공합니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
• 세계 조산 및 PROM 검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 조산 및 PROM 검사 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 유형 발매/승인
• PEST 분석
• PORTER 분석
• 인수합병(M&A) 시나리오

제4장 조산 및 PROM 검사 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 조산 및 PROM 검사 시장, 제품 유형별, 2020년-2032년

• 키트 및 시약
• 기기
• 소모품

제6장 조산 및 PROM 검사 시장, 검사 유형별, 2020년-2032년

• 골반 검사
• 초음파
• 자궁 모니터링
• 바이오마커 검사
• 기타

제7장 조산 및 PROM 검사 시장, 최종사용자별, 2020년-2032년

• 병원
• 진단실험실
• 외래 진료소
• 연구센터
• 기타

제8장 조산 및 PROM 검사 시장, 지역별, 2020년-2032년

• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 중동
  • GCC
  • 이스라엘
  • 기타 중동
• 아프리카
  • 북아프리카
  • 중앙아프리카
  • 남아프리카

제9장 경쟁 구도

• Abbott Laboratories
• Biosynex
• Qiagen N.V.
• Clinical Innovations, LLC
• Sera Prognostics
• Hologic, Inc.
• IQ Products
• NX Prenatal, Inc.
• Promega Corporation
• Insight Pharmaceuticals LLC
• Creative Diagnostics

제10장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Preterm Birth and PROM Testing Market is estimated to be valued at USD 1.92 Bn in 2025 and is expected to reach USD 2.94 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.

Preterm birth, also known as premature birth, is a significant global health concern. It refers to the birth of a baby before 37 completed weeks of gestation. According to the World Health Organization (WHO), around 15 million babies are born prematurely each year, accounting for approximately one in 10 births worldwide. Preterm birth can lead to various health complications and is one of the leading causes of neonatal mortality and morbidity.

PROM testing, which stands for prelabor rupture of membranes, is an important diagnostic tool used to assess the risk of preterm birth. It helps in the early detection of membrane rupture before the onset of labor. By detecting the presence of amniotic fluid, PROM testing helps healthcare professionals make informed decisions regarding the management and care of pregnant women at risk of premature birth.

Market Dynamics:

The preterm birth and PROM testing market is primarily driven by the increasing incidence of preterm births worldwide. Factors, such as maternal age, multiple pregnancies, poor prenatal care, infections, and socioeconomic factors, contribute to the rise in preterm births. PROM testing plays a crucial role in identifying the risk of preterm birth, enabling healthcare professionals to provide timely interventions and improve neonatal outcomes.

However, there are certain restraints that can hinder the growth of the market. These include the high cost of PROM testing kits, limited access to healthcare facilities in developing regions, and the lack of awareness about preterm birth and PROM testing among pregnant women and healthcare providers.

On the other hand, there are significant opportunities in the market, driven by technological advancements in PROM testing methods, increasing focus on point-of-care testing, and the growing demand for personalized medicine. Market players are investing in research and development activities to develop innovative PROM testing kits with improved accuracy, ease of use, and cost-effectiveness.

Overall, the preterm birth and PROM testing market is witnessing substantial growth, driven by the increasing awareness about preterm birth, advancements in PROM testing methods, and the need for early detection and intervention to improve neonatal outcomes. Market players are strategizing to expand their product portfolios, collaborate with key stakeholders, and explore the untapped market potential.

Key Features of the Study:

• This report provides an in-depth analysis of the global preterm birth and PROM testing market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global preterm birth and PROM testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott Laboratories, Biosynex, Qiagen N.V., Clinical Innovations, LLC, Sera Prognostics, Hologic, Inc., IQ Products, NX Prenatal, Inc., PROMega Corporation, Insight Pharmaceuticals LLC, and Creative Diagnostics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global preterm birth and PROM testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preterm birth and PROM testing market

Detailed Segmentation:

• By Product Type
  • Kits and Reagents
  • Instruments
  • Consumables
• By Test Type
  • Pelvic exam
  • Ultrasound
  • Uterine monitoring
  • Biomarker testing
  • Others
• By End User
  • Hospitals
  • Diagnostics laboratories
  • Outpatient clinics
  • Research centers
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • Abbott Laboratories
  • Biosynex
  • Qiagen Sciences LLC
  • Clinical Innovations, LLC
  • Sera Prognostics
  • Hologic, Inc.
  • IQ Products
  • NX Prenatal, Inc.
  • Promega Corporation
  • Medical predictive Technologies Inc.
  • Creative Diagnostics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Preterm Birth And PROM Testing Market, By Product Type
  • Preterm Birth And PROM Testing Market, By Test Type
  • Preterm Birth And PROM Testing Market, By End User
  • Preterm Birth And PROM Testing Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing prevalence of preterm births
  • High costs of prenatal diagnostic tests
  • Significant untapped potential in emerging economies
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Type Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Preterm Birth and PROM Testing Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Preterm Birth and PROM Testing Market, By Product Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Kits and Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

6. Preterm Birth and PROM Testing Market, By Test Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pelvic exam
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Ultrasound
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Uterine monitoring
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Biomarker testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Preterm Birth and PROM Testing Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Diagnostics laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Outpatient clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Research centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

8. Preterm Birth and PROM Testing Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Abbott Laboratories
  • Company Highlights
  • Product Type Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Biosynex
  • Company Highlights
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Qiagen N.V.
  • Company Highlights
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Clinical Innovations, LLC
  • Company Highlights
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sera Prognostics
  • Company Highlights
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hologic, Inc.
  • Company Highlights
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• IQ Products
  • Company Highlights
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• NX Prenatal, Inc.
  • Company Highlights
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Promega Corporation
  • Company Highlights
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Insight Pharmaceuticals LLC
  • Company Highlights
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Creative Diagnostics
  • Company Highlights
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us